ArticleFrontiers in oncology2026
Nomogram combining clinical and ultrasonographic features for differentiating granulomatous lobular mastitis from invasive lobular carcinoma.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aims to develop and validate a nomogram model based on clinical and ultrasonographic features for differentiating granulomatous lobular mastitis (GLM) from invasive lobular carcinoma (ILC) of the breast in clinical practice and evaluate its diagnostic performance and clinical utility. Methods: A total of 205 patients with pathologically confirmed GLM and 166 patients with ILC were retrospectively enrolled and randomly allocated to training and validation cohorts in a 7:3 ratio. Clinical data and ultrasonographic characteristics were collected. Univariate analysis was performed to compare variables between GLM and ILC groups. Variables with statistical significance were subsequently entered into multivariate logistic regression analysis to identify independent predictors. A visual nomogram model was constructed based on these predictors. Model performance was evaluated using receiver operating characteristic curves and the area under the curve. Calibration curves were plotted to evaluate the agreement between predicted probabilities and observed outcomes. Decision curve analysis (DCA) was conducted to assess the clinical net benefit of the model. Results: Univariate analysis revealed significant differences across several clinical and ultrasonographic features between GLM and ILC ( Conclusion: A nomogram integrating clinical and ultrasonographic features was developed and validated, demonstrating robust discrimination, satisfactory calibration, and favorable clinical utility in differentiating GLM from ILC. As a noninvasive and visually intuitive tool, this model requires external validation, it still may facilitate more precise diagnostic and therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.